10
Oct 2025
The rapid advancement of artificial intelligence (AI) is transforming the field of structural biology. In May 2024, DeepMind and Isomorphic Labs launched AlphaFold 3 (AF3), a revolutionary AI system capable of predicting the 3D structures and interactions of proteins, nucleic acids, small molecules, ions, and other biomolecules with remarkable precision.
10
Oct 2025
The European Commission and WHO have both emphasized the urgent need to address societal challenges in mental health, highlighting that young people are especially vulnerable and require immediate support.
10
Oct 2025
Liver fibrosis, a progressive scarring of the liver tissue, represents a major global health burden with limited treatment options.
10
Oct 2025
UVA Health lung researchers are developing a promising approach to detecting patients at risk of interstitial lung disease (ILD), an increasingly common condition that is a leading reason for lung transplants.
10
Oct 2025
New research has discovered that briefly altering how we perceive our own body can help unlock autobiographical memories – potentially even those from the early stages of childhood.
10
Oct 2025
Respiratory viral diseases pose severe threats to animal health and global food security, especially in intensive pig farming systems.
10
Oct 2025
Chikungunya is a vector-borne disease that affects both adults and children. While global efforts are ongoing to tackle chikungunya in adults, progress in addressing pediatric chikungunya remains inadequate.
10
Oct 2025
Sepsis is a complex clinical syndrome characterized by dysregulated immune responses, systemic inflammation, and multi-organ dysfunction.
10
Oct 2025
Conventional studies on stem cell fates are primarily focused on transcription factors, with the limited consideration for 3D genome architecture.
10
Oct 2025
Abdominal aortic aneurysm (AAA) is a life-threatening vascular disorder that primarily affects elderly males.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
